NLRP3 and cancer: Due to the flagellin-induced IL6, which is known to inhibit apoptosis in many cancer cell types [36], we measured the effects of flagellin on the caspase-1 activity of the C26 cells together with either TLR5 antagonist or genipin, which inhibits NLRP3-mediated inflammasome activation [37].